Erick Gamelin
Corporate Officer/Principal chez ACRIVON THERAPEUTICS, INC.
Fortune : 150 470 $ au 30/04/2024
Profil
Erick Gamelin is currently the Chief Development Officer at Acrivon Therapeutics, Inc. He previously held positions as the Vice President-Oncology at Dynavax Technologies Corp., Vice President at MacroGenics, Inc., and Chief Medical Officer at Step Pharma SAS.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 14/05/2024 | 17 765 ( 0,06% ) | 150 470 $ | 30/04/2024 |
Postes actifs de Erick Gamelin
| Sociétés | Poste | Début |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 03/01/2024 |
Anciens postes connus de Erick Gamelin
| Sociétés | Poste | Fin |
|---|---|---|
Step Pharma SAS
 Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Directeur Technique/Scientifique/R&D | 01/01/2021 |
| DYNAVAX TECHNOLOGIES CORPORATION | Corporate Officer/Principal | 01/10/2019 |
| MACROGENICS, INC. | Corporate Officer/Principal | 01/03/2018 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ACRIVON THERAPEUTICS, INC. | Health Technology |
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| MACROGENICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Step Pharma SAS develops drugs for immunosuppressive therapies. The company was founded by Geoffroy de Ribains, Alain Fischer, and Sylvain Latour and is headquartered in Paris, France. | Health Technology |